Early Safety and Efficacy Outcomes of a Novel 360° Canaloplasty Device in Open-Angle Glaucoma: A Retrospective Cohort Study.

Clin Ophthalmol · 2026 · PMC13200206 · PMID 42199328

Europe PMC DOI

hedged sentence

0.1331

closest p · 2.7× alpha

0.1331

boldest claim

The sentences

did not reach statistical significanceP = 0.1331not close (p > 0.1)

The mean (SD) number of glaucoma medications decreased from 1.48 (1.08) at baseline to 1.13 (1.16) at 6 months, representing a 23.64% reduction; however, this change did not reach statistical significance compared with baseline (P = 0.1331).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.